Your session is about to expire
← Back to Search
OCT-Guided Coronary Bypass Grafting for Graft Failure (OCTOCAB Trial)
OCTOCAB Trial Summary
This trial will compare optical coherence tomography-guided saphenous vein grafting to the standard of care in coronary artery bypass surgery to see if it reduces the rate of early vein graft failure.
OCTOCAB Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOCTOCAB Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OCTOCAB Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am undergoing or have undergone surgery on multiple heart valves or the main artery coming from my heart.I have had coronary artery bypass surgery.My heart failure is not severe (below Killip class 3 or NYHA class 4).I am on long-term medication to suppress my immune system due to severe autoimmune disease.I have had a heart transplant.I do not have irregular heartbeats that are severe and uncontrolled.I had a severe heart attack less than 24 hours ago.My heart's pumping ability is severely reduced.My kidney function is low, but I am not on dialysis.I do not need machines or IV drugs to maintain my blood pressure.I am scheduled for a non-heart-related surgery within the next 2 years.I am scheduled for a heart artery procedure within the next 2 years.I have a history of bleeding disorders.I have heart issues that may require bypass surgery.I am 18 years old or older.I am allergic or react badly to the drugs used in this study.I have had or will have radiation therapy to my heart area or chest.I have a liver condition.I have a heart blockage that can be treated with a vein graft.
- Group 1: OCT-guided saphenous vein graft coronary artery bypass graft surgery
- Group 2: Visual inspection-guided saphenous vein graft coronary artery graft surgery
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
What is the cohort size for this clinical trial?
"Yes, the information on clinicaltrials.gov conclusively indicates that this research project is currently recruiting participants. The trial was first posted on April 4th 2022 and its most recent update occurred May 4th 2022 - with a total of 760 individuals sought from one medical centre."
Is this clinical investigation currently open to participants?
"According to clinicaltrials.gov, this medical trial is seeking participants and has been updated as recently as May 4th 2022. The experiment was first posted on April 4th of the same year."
Share this study with friends
Copy Link
Messenger